Contact Us at Sunridge Medical

Cutting-Edge Treatment Options. Call Today! 1.800.923.7878

Contact Us
Call Today! 1.800.923-7878
Sunridge Medical
"
Antioxidant Biology · Integrative Oncology

IV Glutathione and Cancer: Evidence, Timing and Safety

Glutathione is a tripeptide made by the body that helps regulate oxidative stress, detoxification enzymes and cellular redox signaling. Intravenous glutathione has been studied as an adjunct to reduce selected chemotherapy toxicities, but it is not a proven standalone cancer treatment—and its timing may matter because some cancer therapies use oxidative damage.

At Sunridge Medical, IV glutathione questions are reviewed in the context of the exact cancer treatment, the intended supportive goal, product quality, kidney and liver function, and the evidence for that specific combination.

Supportive evidence explainedAntioxidant timing reviewedSterile quality prioritized
Request an Integrative Review →Call 1-800-923-7878
Glutathione molecules and cellular redox balance in a scientific cancer treatment research visualization
Glutathione has different roles in healthy tissue, treatment toxicity and tumor biology, so “more antioxidant” is not automatically better.
“
IV glutathione consultation

Coordinate IV Glutathione With Your Oncology Treatment

Timing, treatment goals, kidney function, medications and the oncology regimen all matter. A Sunridge physician can determine whether IV glutathione has a reasonable supportive role and how response should be monitored.

  • Infusion timing is coordinated with active cancer treatment
  • Laboratory status and treatment tolerance are reviewed
  • Call now for an immediate response from our Patient Care Team
Call 1-800-923-7878 →
IV glutathione consultation

Speak With Our Patient Care Team

Share your diagnosis, current treatment and goal for IV glutathione. We will help you prepare for physician review.

* Required fields
Prefer to speak with someone now?
1-800-923-7878
  • Infusion timing is coordinated with active cancer treatment
  • Laboratory status and treatment tolerance are reviewed
  • Questions before scheduling are always welcome
Glutathione · Key Points

What Patients Should Know First

Normal Biology

The body already makes glutathione

It participates in peroxide reduction, drug metabolism, protein regulation and protection from oxidative injury.

Supportive Evidence

Older cisplatin trials reported benefits

Some randomized studies found less toxicity, more completed chemotherapy and better quality-of-life measures.

Uncertainty

Evidence is not universal

Results from cisplatin-era ovarian cancer trials cannot be applied to every cancer, drug, dose or infusion schedule.

Cancer Treatment

Not a proven tumor-directed therapy

IV glutathione has not been shown to cure cancer or replace surgery, radiation, chemotherapy, immunotherapy or targeted treatment.

“
Understanding Redox Biology

Glutathione Can Protect Cells—and Cancer Cells Also Use It

Healthy tissue

Reduced glutathione helps neutralize peroxides and reactive intermediates. That can be relevant when normal tissue is injured by treatment or inflammation.

Tumor biology

Some cancer cells increase glutathione synthesis or related enzymes to tolerate oxidative stress and resist drugs. Researchers also study strategies that deplete tumor glutathione.

Context is the treatment

An antioxidant can be helpful in one setting and counterproductive in another. The route, timing, tumor biology and mechanism of the cancer therapy all influence the risk–benefit discussion.

“
Human Evidence

What the Cisplatin Studies Found

A double-blind randomized trial of 151 women receiving cisplatin for ovarian cancer found that patients assigned glutathione were more likely to complete six courses, had less decline in creatinine clearance and reported better scores for several quality-of-life and toxicity measures. Tumor response showed a nonsignificant trend favoring glutathione.

A smaller randomized study in relapsed ovarian cancer reported a trend toward neuroprotection without a reduction in tumor response. These results are encouraging for a specific adjunctive use, but they are older, regimen-specific and not enough to establish benefit across modern oncology.

Best interpretation: glutathione may reduce selected platinum toxicities in some settings, but contemporary treatment-specific guidance and monitoring are still required.
“
Chemotherapy-Induced Neuropathy

Promising Signals Have Not Produced a Universal Recommendation

A Cochrane review found insufficient objective evidence to conclude that glutathione or other proposed protectants reliably prevent platinum neuropathy, even though pooled subjective toxicity grading favored glutathione. A broader nutraceutical review similarly concluded that no agent had solid enough evidence for routine prevention or treatment of chemotherapy-induced peripheral neuropathy.

  • Document neuropathy before starting or changing treatment
  • Identify the causative chemotherapy and cumulative exposure
  • Consider dose modification and evidence-based symptom management
  • Do not use glutathione to delay reporting new weakness or balance problems
  • Coordinate antioxidant timing with the prescribing oncologist
“
Treatment Coordination

Why Timing Cannot Be Standardized Across Every Cancer Drug

Oncology physicians reviewing IV glutathione timing and chemotherapy safety with a cancer patient
A safe plan considers the mechanism and schedule of every cancer drug—not simply whether a therapy is called an antioxidant.

Some chemotherapy and radiation strategies generate reactive oxygen species as part of their anticancer effect. Other regimens have studied glutathione specifically as a protective adjunct. This makes a single rule such as “always avoid” or “always give” scientifically inadequate.

  • Review the exact drug, dose and infusion day
  • Separate oral supplements from IV exposure
  • Consider tumor type and treatment intent
  • Coordinate with radiation and medical oncology
  • Define the supportive outcome being targeted
“
Sterile Compounding

IV Ingredient Quality Is a Clinical Safety Issue

The FDA investigated adverse events after compounded glutathione injections made from ingredient material intended only for dietary-supplement use. Excess bacterial endotoxin was found, and patients experienced nausea, vomiting, chills, body aches, low blood pressure and breathing difficulty.

Current recall information matters

In 2026, the FDA posted a voluntary recall of certain compounded glutathione 200 mg/mL multidose vials because of elevated endotoxin levels and reported reactions. Before any infusion, the pharmacy, lot, beyond-use date and recall status must be verified.

Sterility, endotoxin control, ingredient suitability, cold-chain handling and traceability are not administrative details. They are part of the treatment.

“
Sunridge Medical Approach

Use Glutathione for a Defined Supportive Goal

A physician-directed plan begins with the problem being addressed—not a generic “detox” claim. The decision may involve chemotherapy toxicity, nutritional status, liver or kidney function, oxidative stress, medication interactions or recovery.

1 · Define

What outcome is being targeted?

Neuropathy, renal toxicity, fatigue and general wellness are different goals requiring different evidence.

2 · Coordinate

What cancer therapy is active?

The treating oncologist’s regimen and timing should guide antioxidant decisions.

3 · Verify

Is the product appropriate for injection?

Confirm pharmacy source, sterility controls, endotoxin testing and recall status.

4 · Monitor

Is the intended benefit occurring?

Track symptoms, treatment completion, labs and adverse effects rather than assuming biochemical benefit.

Related reading: Explore alpha-lipoic acid, intravenous vitamin C and our cancer treatment resources.
“
Frequently Asked Questions

IV Glutathione and Cancer Questions

What is glutathione?

Glutathione is a tripeptide made from glutamate, cysteine and glycine. It participates in antioxidant defense, detoxification reactions and redox signaling.

Does IV glutathione kill cancer?

It is not a proven standalone cancer treatment. Its best-known clinical research in oncology concerns supportive use with selected chemotherapy regimens.

Can glutathione reduce cisplatin side effects?

Older randomized studies reported less toxicity and better quality-of-life measures in some ovarian-cancer regimens, but evidence is not universal across cancers or drugs.

Can glutathione prevent chemotherapy neuropathy?

Some studies are encouraging, but systematic reviews find the evidence insufficient for a general recommendation. Treatment-specific discussion is needed.

Could antioxidants protect cancer cells?

Some tumors use glutathione pathways to resist oxidative stress, and some therapies depend partly on oxidative damage. This is why timing and context matter.

Is oral glutathione the same as IV glutathione?

No. Absorption, peak exposure, formulation and evidence differ by route.

Is IV glutathione FDA approved for cancer?

No. Compounded IV glutathione is not an FDA-approved cancer treatment.

What are the infusion risks?

Possible reactions include nausea, chills, headache, breathing symptoms and blood-pressure changes. Contamination or endotoxin exposure can cause severe reactions.

How is sterile quality checked?

The clinician should verify an appropriate pharmacy source, lot traceability, sterility and endotoxin controls, storage and current recall status.

Can Sunridge review glutathione with my chemotherapy?

Yes. Bring the exact chemotherapy schedule, supplement list, symptoms and recent laboratory results for a coordinated review.

“
Primary Sources & Evidence Reviews

References

  1. National Cancer Institute. Glutathione Drug Dictionary.
  2. Smyth JF, et al. Glutathione With Cisplatin in Ovarian Cancer: Double-Blind Randomized Trial. Ann Oncol. 1997.
  3. Weekly Cisplatin With or Without Glutathione in Relapsed Ovarian Cancer. 1995.
  4. Cochrane Review. Interventions for Preventing Platinum-Related Neuropathy. 2014.
  5. Nutraceuticals and Chemotherapy-Induced Peripheral Neuropathy: Systematic Review. 2013.
  6. National Cancer Institute. Cancer Therapy Interactions With Foods and Dietary Supplements.
  7. National Cancer Institute. Antioxidants During Cancer Treatment, Patient Version.
  8. FDA. Concerns With Dietary-Ingredient Glutathione in Sterile Injectables.
  9. FDA. 2026 Recall of Compounded Glutathione for Elevated Endotoxin.
  10. National Cancer Institute. Antioxidants, Glutathione and Tumor Metastasis Research.
  11. National Cancer Institute. Glutathione Disulfide NOV-002.
  12. FDA Warning Letter Concerning Compounded Injectable Glutathione Quality.

This page is educational. IV glutathione is not a proven standalone cancer treatment. Antioxidant timing and sterile-product quality require treatment-specific medical oversight.

“
Considering Glutathione During Cancer Treatment?

Coordinate the Goal, Timing and Product With the Full Treatment Plan

Our Patient Care Team can help determine which oncology records, infusion details and laboratory results are needed for an integrative review.

Request a Cancer Consultation →Call 1-800-923-7878
“
“
Living research library · positive published findings

Research organized by cancer type

Browse 14 source-linked studies with the full title, publication year, research focus and a concise finding. Select any linked cancer type to move directly to its corresponding Sunridge page.

Bladder cancer

HSPE1 Inhibits Bladder Cancer Ferroptosis via a Glutathione-Dependent Mechanism by Suppressing GPX4.

2024 · Apoptosis and cell death

In cancer cells, HSPE1 promoted GSH accumulation, decreased lipid peroxidation, and inhibited cell ferroptosis, as demonstrated in a rescue experiment with the ferroptosis inhibitor Fer-1.

Open study on PubMed →
Brain cancer

Curzerene suppresses progression of human glioblastoma through inhibition of glutathione S-transferase A4.

2022 · Tumor growth and proliferation

Curzerene was found to inhibit the expression of GSTA4 mRNA and protein in U251 and U87 glioma cells, and this effect correlated with a downregulation of the proliferation of these cells in a time- and dose-dependent manner.

Open study on PubMed →
Cervical cancer

Identification of Glutathione Synthetase as a Therapeutic Target for Cervical Cancer via Combining Bioinformatics and Experimental Validation.

2025 · Tumor growth and proliferation

Drug sensitivity analysis linked GSS to vorinostat, which inhibits tumour growth by suppressing the PI3K/Akt pathway and downregulating GSS.

Open study on PubMed →
Colorectal cancer

Quercetin-Induced Glutathione Depletion Sensitizes Colorectal Cancer Cells to Oxaliplatin.

2023 · Treatment response

Furthermore, the incorporation of sulforaphane, recognized for its ability to scavenge glutathione, in combination with quercetin and oxaliplatin, substantially suppressed tumor growth in an HCT116 xenograft mouse model.

Open study on PubMed →
Esophageal cancer

Inhibition of glutathione metabolism attenuates esophageal cancer progression.

2017 · Metabolism and redox biology

In addition, treatment with L-buthionine-sulfoximine (BSO) to deplete glutathione decreased the ESCC tumor burden in mice, thus demonstrating the critical role of glutathione metabolism in ESCC progression.

Open study on PubMed →
Gastric cancer

Glutathione peroxidase 2 knockdown suppresses gastric cancer progression and metastasis via regulation of kynurenine metabolism.

2023 · Metastasis and invasion

Glutathione peroxidase-2 (GPx2) plays various roles in tumor progression and patient survival.

Open study on PubMed →
Gastric cancer

Inhibition of glutathione peroxidase 4 suppresses gastric cancer peritoneal metastasis via regulation of RCC2 homeostasis.

2025 · Metastasis and invasion

Glutathione peroxidase 4 (GPx4), a key regulator of ferroptosis and redox homeostasis, contributes to progression and influences patient survival.

Open study on PubMed →
Head and neck cancer

Down-regulation of Glutathione Peroxidase 4 in Oral Cancer Inhibits Tumor Growth Through SREBP1 Signaling.

2021 · Tumor growth and proliferation

This study aimed to elucidate the role of glutathione peroxidase 4 (GPX4) on the sterol regulatory element binding proteins (SREBPs)-proliferation pathway in oral cancer cells, and determine its protein expression in oral cancer tissues.

Open study on PubMed →
Lymphoma

Glutathione overproduction mediates lymphoma initiating cells survival and has a sex-dependent effect on lymphomagenesis.

2024 · Cancer biology and response

A subset of lymphoma cells, characterized by an increased abundance of the antioxidant glutathione, escape ROS-induced lethality, a response not seen in non-tumor cells.

Open study on PubMed →
Lymphoma

Glutathione-S-transferases and Chemotherapy Resistance of Hodgkin's Lymphoma Cell Lines.

2016 · Treatment response

Glutathione-S-transferases (GSTs) are associated with multidrug resistance of tumor cells and are involved in drug detoxification and control of apoptosis.

Open study on PubMed →
Melanoma

Microsomal glutathione transferase 1 controls metastasis and therapeutic response in melanoma.

2023 · Metastasis and invasion

When compared to control, mice bearing Mgst1 KD B16 tumors had more CD8+ T cell infiltration with reduced expression of inhibitory receptors and increased cytokine response, large reduction of lung metastases and enhanced survival.

Open study on PubMed →
Pancreatic cancer

Inhibition of glutathione metabolism can limit the development of pancreatic cancer.

2022 · Apoptosis and cell death

Nevertheless, buthionine-sulfoximine also decreases the content of glutathione in normal cells, disrupts the balance between reactive oxygen species and glutathione, and eventually induces cell apoptosis.

Open study on PubMed →
Testicular cancer

Selective induction of glutathione S-transferases in round spermatids from the Brown-Norway rat by the chemotherapeutic regimen for testicular cancer.

2013 · Cancer biology and response

As GSTs are involved in drug resistance mechanisms, we hypothesize that BEP induction of GST expression may lead to the survival of damaged germ cells and the production of abnormal sperm.

Open study on PubMed →
Uterine cancer

Impact of the glutathione synthesis pathway on sulfasalazine-treated endometrial cancer.

2022 · Treatment response

Sulfasalazine treatment significantly decreased intracellular glutathione levels and induced apoptosis when combined with cisplatin in USC cell lines.

Open study on PubMed →

Scottsdale Clinic

14200 N Northsight Blvd #160
Scottsdale, Arizona 85260

Call Our Care Team

Toll-free: 1-800-923-7878
Local: 480-659-9135

Email

info@sunridgemedical.com

Office Hours

Monday–Friday: 9:00 AM–5:00 PM
Saturday: 9:00 AM–12:00 PM

Visit Sunridge in Scottsdale

FREE INTRODUCTORY CALL

Speak With Our Patient Care Team

Tell us what you are facing. There is no charge to speak with our Patient Care Team, understand how Sunridge works and determine whether a physician consultation may be an appropriate next step.

Call Now: 1-800-923-7878

This introductory call is not a medical consultation and does not establish a physician-patient relationship.

Have a Question or Share Feedback:
It's easy to get in touch with us